I found this on the World Heath Organisation website 'Sex and Reproductive Health' section
"The June 2009 issue of the Journal of Clinical Endocrinology and Metabolism includes the report of the results of a Phase III efficacy and safety trial of a long-acting androgen for male contraception. This multicentre study was supported by RHR/HRP to assess the potential of monthly injections of testosterone undecanoate to provide an effective, safe and reversible contraceptive method for men"
Go here to read more
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment